Ethambutol optic neuropathy in a hemodialysis patient receiving a guideline-recommended dose
Related Experiment Video
Updated: May 6, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Bridget A Scoville1, Lindsey B De Lott, Jonathan D Trobe
1Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York Department of Neuro-Ophthalmology, University of Michigan Kellogg Eye Center, Ann Arbor, Michigan Department of Neuro-Ophthalmology, University of Michigan Kellogg Eye Center, Ann Arbor, Michigan Department of Clinical, Social and Administrative Sciences, University of Michigan College of Pharmacy, Ann Arbor, Michigan.
No abstract available in PubMed .
Related Concept Videos
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Hemodialysis I: Introduction
